P1 ‐165: Hepatitis B core immunoglobulin G antibody (Anti‐HBc IgG) avidity index to differentiate acute from chronic hepatitis B virus (HBV) infection in cases with persistent anti‐HBc immunoglobulin M (Anti‐HBc IgM)
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 109-109, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P1 ‐085: Utilization and effectiveness of Elbasvir/Grazoprevir (EBR/GZR) in treatment Naïve (TN) genotype 1a (G1a) chronic hepatitis C virus (HCV) patients with/without baseline NS5A resistance‐associated substitutions (RASs)
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 66-66, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P2 ‐148: Immunogenicity and safety of 60 μg hepatitis B vaccine with rapid immunization compared with traditional 20 μg regimens in adults aged 25–55 in China
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 179-180, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

LBO ‐02: Utility of a new HBV RNA assay in HBeAg positive and negative CHB and following HBsAg seroclearance in patients treated with ARC‐520, an RNAi drug targeting cccDNA derived HBV mRNA
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 190-191, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P1 ‐041: Generating CD4+ T cells for the T‐cell therapy of HBV infection
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 47-47, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

O ‐028: Directly acting antiviral HCV therapy is safe and effective in patients with advanced cirrhosis: real world experience from the HCV‐TARGET cohort
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 18-19, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P2 ‐102: A systematic decision tool to support the selection of innovative financing mechanisms for treatment access programs in resource‐limited settings utilizing Hepatitis C in Mongolia as a case study
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 158-159, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P1 ‐173: Prevalence and risk factors for hepatitis B infection in men in the penitentiary system in Paraná, Brazil
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 111-112, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P1 ‐091: Treatment rates and toxicity for Hodgkin disease associated with viral hepatitis C and HIV
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 70-71, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P2 ‐154: Efficacy of hepatitis B virus vaccination in genotype 4 chronic hepatitis C patients achieved sustained virologic response with direct acting antivirals
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 183-184, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P2 ‐054: Usefulness of saliva samples for HCV RNA detection: important tool to increase diagnosis access in low resource areas
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 133-134, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P1 ‐130: Efficient dried blood spot‐based determination of Hepatitis B seroprevalence from a national survey in the democratic republic of the congo
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 92-93, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P1 ‐052: Expression of metastatic tumor antigen 1 correlates with tumor and clinical features of patients with hepatitis B virus‐related hepatocellular carcinoma
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 50-50, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

O ‐035: Early function modulation and reprogramming of liver resident and infiltrating macrophages promote the establishment of HBV infection
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 22-23, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P2 ‐005: Hepatitis D virus infection in Canada: molecular epidemiology and clinical association
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 115-116, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research